Similarly, DPI treatment of KCs from NAFLD patients upregulated the glycolysis pathway and response to hypoxia but downregulated pro-inflammatory pathways at the transcription level (Fig. 7f, g). The gene discussed is TBCE; the disease is metabolic dysfunction-associated steatotic liver disease.